Mayo clinic to integrate blockchain technology for clinical data trail

Dutch blockchain startup Triall announced a partnership with US nonprofit medical center Mayo Clinic to integrate blockchain technology to embed verifiable clinical data as part of a clinical design trial involving 10 research sites and over 500 patients. The trail will start in September 2022 and take place in the U.S.

Traill’s eClinical platform will work with researchers at the American healthcare firm on a multi-center pulmonary arterial hypertension trial over the next two years.

The eClinical solutions of Triall will support all core trial activities, including data capture, document management, study monitoring, and eConsent.

The collaboration looks to demonstrate the potential of an immutable public ledger audit trail through its blockchain technology to boost clinical data integrity. All stakeholders, investigators and regulators can then review and assess clinical trial-related data with confidence that the data cannot be manipulated.

‘We are very excited to further our collaboration with Mayo Clinic and the team of Dr. Chris McLeod. It is wonderful to work with some of the thought leaders within Mayo Clinic and we are confident our collaboration will pave the way towards further innovation and enhanced quality in clinical development, utilizing the strengths of blockchain technology where these truly add value,’ said Hadil Es-Sbai, co-founder and CEO at Triall.

Photo: wolterke /Depositphotos